A start-up vendor has teamed with web search giant Google to offer a free electronic health record system to physicians. The service, now in beta version from Practice Fusion, is believed to be the first on-demand medical records product available to physicians at no cost.
A start-up vendor has teamed with web search giant Google to offer a free electronic health record system to physicians. The service, now in beta version from Practice Fusion, is believed to be the first on-demand medical records product available to physicians at no cost.
"The cost of electronic medical record systems is one of the major barriers to adoption," said Practice Fusion CEO Ryan Howard.
EHR systems typically cost $20,000 or more to implement. The Practice Fusion model circumvents this cost, allowing practitioners to adopt EHR technology with no financial risk. The service finances itself with advertising generated through Google's AdSense system and displayed as the records system is used.
Eventually, the system could handle such radiology-related data as reports and perhaps even digital images, Howard said.
The EHR service is separate from Google, which merely drives the application. Google will not handle any of the patient data passing through it. Data will reside in a central repository owned and controlled by Practice Fusion.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.